 |
Subscribe / Renew |
 |
Contact Us |
| ► Subscribe to our Free Weekly Newsletter | |
Construction Bids
| home | Welcome, sign in or click here to subscribe. | login |
Business
 print  email to a friend  reprints add to mydjc |  |
January 23, 2006
Targeted Genetics
Targeted Genetics named David J. Poston vice president, finance, chief financial officer and treasurer. Poston has been acting chief financial officer since October 2005. The biotech company is involved in therapies for diseases such as inflammatory arthritis and HIV/AIDS.